1-4 of 4
Erik Marijt
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Efficacy and Toxicity of Donor Lymphocyte Infusions in the Management of Mixed Donor-Recipient Chimerism Following Allogeneic Stem Cell Transplantation for Lymphoid Malignancies:- a Study of the LWP-EBMT

Stephen Robinson, MBBS, PhD BSc, Ariane Boumendil, PhD, Irma Khvedelidze, Hervé Finel, Karl Peggs, MBBChir, Ram K Malladi, FRCPath, Victoria Potter, Anna Tsoulkani, Elisabeth Vandenberghe, MD PhD, Yves Chalandon, MD PhD, Jürgen Finke, MD, Erik Marijt, MD, Sabine Furst, MD, Michel Schaap, MD PhD, Hannah Hunter, MB,FRCPath, MRCP, John A Snowden, MD PhD, Karan Wadehra, Sebastian Wittnebel, Dietrich W. Beelen, Nathalie Fegueux, Nicolaus Kroeger, MD, Peter Dreger, Silvia Montoto, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2070.
https://doi.org/10.1182/blood-2018-99-114072
Published: 2018
Journal Articles

Multiple myeloma–reactive T cells recognize an activation-induced minor histocompatibility antigen encoded by the ATP-dependent interferon-responsive (ADIR) gene

Cornelis A. M. van Bergen, Michel G. D. Kester, Inge Jedema, Mirjam H. M. Heemskerk, Simone A. P. van Luxemburg-Heijs, Freke M. Kloosterboer, W. A. Erik Marijt, Arnoud H. de Ru, M. Ron Schaafsma, Roel Willemze, Peter A. van Veelen, J. H. Frederik Falkenburg
Journal: Blood
Blood (2007) 109 (9): 4089–4096.
https://doi.org/10.1182/blood-2006-08-043935
Published: 2007
Journal Articles

Identification of the angiogenic endothelial-cell growth factor-1/thymidine phosphorylase as a potential target for immunotherapy of cancer

Elisabeth H. Slager, M. Willy Honders, Edith D. van der Meijden, Simone A. P. van Luxemburg-Heijs, Freke M. Kloosterboer, Michel G. D. Kester, Inge Jedema, W. A. Erik Marijt, M. Ron Schaafsma, Roel Willemze, J. H. Frederik Falkenburg
Journal: Blood
Blood (2006) 107 (12): 4954–4960.
https://doi.org/10.1182/blood-2005-09-3883
Published: 2006
Journal Articles

Identification of the Angiogenic Endothelial Cell Growth Factor-1/Thymidine Phosphorylase as a Target for Immunotherapy of Cancer.

Elisabeth H. Slager, PhD, M. Willy Honders, Edith D. van der Meijden, Simone A.P. van Luxemburg-Heijs, Freke M. Kloosterboer, PhD, Michel G.D. Kester, Inge Jedema, PhD, W.A. Erik Marijt, PhD, MD, M. Ronald Schaafsma, PhD, MD, J.H. Frederik Falkenburg, PhD, MD, Roel Willemze, PhD, MD
Journal: Blood
Blood (2005) 106 (11): 3094.
https://doi.org/10.1182/blood.V106.11.3094.3094
Published: 2005